Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Announce 2012 Third Quarter Financial Results on October 30, 2012

DUBLIN, Calif, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
October 15, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Scientists Publish the Discovery of Novel Allosteric Modulators for the Key Therapeutic Targets HCV NS3 and PKM2 in Nature Journals

DUBLIN, Calif., Oct. 15, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
October 10, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces the Appointment of President Harren Jhoti, PhD to the BioIndustry Association Board of Directors

DUBLIN, Calif., Oct. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
October 09, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Earns $5 Million for First Commercial Sale of DACOGEN(R) in the European Union

DUBLIN, Calif., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
October 02, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Platinum-Resistant Recurrent Ovarian Cancer Patients

DUBLIN, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
October 02, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Present at BIO Investor Forum

DUBLIN, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
September 28, 2012 06:20 ET | Source: Astex Pharmaceuticals, Inc.

DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia

DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
September 21, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program

DUBLIN, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
September 18, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals to Participate on Oncology Panels at Upcoming Investor Conferences

DUBLIN, Calif., Sept. 18, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
September 10, 2012 06:00 ET | Source: Astex Pharmaceuticals, Inc.

Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients

DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right